BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9600699)

  • 1. Effect of cancer chemopreventive agents on microsome-mediated DNA adduction of the breast carcinogen dibenzo[a,l]pyrene.
    Smith WA; Arif JM; Gupta RC
    Mutat Res; 1998 Feb; 412(3):307-14. PubMed ID: 9600699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7.
    Smith WA; Freeman JW; Gupta RC
    Mutat Res; 2001 Sep; 480-481():97-108. PubMed ID: 11506803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsome-mediated bioactivation of dibenzo[a,l]pyrene and identification of DNA adducts by 32P-postlabeling.
    Arif JM; Gupta RC
    Carcinogenesis; 1997 Oct; 18(10):1999-2007. PubMed ID: 9364012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA adduct formation and persistence in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene.
    Arif JM; Smith WA; Gupta RC
    Carcinogenesis; 1999 Jun; 20(6):1147-50. PubMed ID: 10357803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation.
    Russell GK; Gupta RC; Vadhanam MV
    Mutat Res; 2015 Apr; 774():25-32. PubMed ID: 25794985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents.
    Smith WA; Gupta RC
    Carcinogenesis; 1996 Jun; 17(6):1285-90. PubMed ID: 8681444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining efficacy of cancer chemopreventive agents using a cell-free system concomitant with DNA adduction.
    Smith WA; Gupta RC
    Mutat Res; 1999 Mar; 425(1):143-52. PubMed ID: 10082925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene.
    Arif JM; Smith WA; Gupta RC
    Mutat Res; 1997 Aug; 378(1-2):31-9. PubMed ID: 9288883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of carcinogen dose in chemoprevention studies: quantitative interrelationships between, dibenzo[a,l]pyrene dose, chlorophyllin dose, target organ DNA adduct biomarkers and final tumor outcome.
    Pratt MM; Reddy AP; Hendricks JD; Pereira C; Kensler TW; Bailey GS
    Carcinogenesis; 2007 Mar; 28(3):611-24. PubMed ID: 16973675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Black Raspberry Extract and Protocatechuic Acid on Carcinogen-DNA Adducts and Mutagenesis, and Oxidative Stress in Rat and Human Oral Cells.
    Guttenplan JB; Chen KM; Sun YW; Kosinska W; Zhou Y; Kim SA; Sung Y; Gowda K; Amin S; Stoner GD; El-Bayoumy K
    Cancer Prev Res (Phila); 2016 Aug; 9(8):704-12. PubMed ID: 27267891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2-dithiole-3-thione and its structural analogue oltipraz are potent inhibitors of dibenz.
    Smith WA; Arif JM; Gupta RC
    Int J Cancer; 2001 Jan; 91(1):132-6. PubMed ID: 11149412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies.
    Jankowiak R; Ariese F; Hewer A; Luch A; Zamzow D; Hughes NC; Phillips D; Seidel A; Platt KL; Oesch F; Small GJ
    Chem Res Toxicol; 1998 Jun; 11(6):674-85. PubMed ID: 9625736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC
    Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and differential repair of covalent DNA adducts generated by treatment of human cells with (+/-)-anti-dibenzo[a,l]pyrene-11,12-diol-13,14-epoxide.
    Spencer WA; Singh J; Orren DK
    Chem Res Toxicol; 2009 Jan; 22(1):81-9. PubMed ID: 19053321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung.
    Prahalad AK; Ross JA; Nelson GB; Roop BC; King LC; Nesnow S; Mass MJ
    Carcinogenesis; 1997 Oct; 18(10):1955-63. PubMed ID: 9364006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland.
    Todorovic R; Devanesan P; Rogan E; Cavalieri E
    Chem Res Toxicol; 2005 Jun; 18(6):984-90. PubMed ID: 15962933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for the isolation and identification of stable DNA adducts formed by Dibenzo[a,l]pyrene and Dibenzo[a,l]pyrene 11, 12-dihydrodiol 13,14-epoxides in vitro.
    Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1999 Sep; 12(9):796-801. PubMed ID: 10490500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
    King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
    Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.